Nov 12, 2022 10:51 am | 1 minute read
Former Louisiana Attorney General Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Isoray, Inc (“the Company”) ISR with Viewpoint Molecular Targeting, Inc., whereby Viewpoint shareholders will ultimately own 49% of Isoray’s fully diluted outstanding common stock. KSF is attempting to determine whether the merger and the process leading up to it are reasonable and fair to the company’s shareholders.
If you would like to discuss your legal rights in relation to the Proposed Sale you may email or call KSF Managing Partner Lewis S. Kahn, without obligation and at no cost to you (lewis.kahn@ksfcounsel.com) anytime toll-free at 855-768-1857 or visit us https://www.ksfcounsel.com/cases/nyse-isr/ to learn more.
To learn more about KSF, which partners with the former Louisiana Attorney General, visit www.ksfcounsel.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221112005059/en/
© 2022 Benzinga.de. Benzinga does not provide investment advice. All rights reserved.
